© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
September 11, 2008
Cardiac resynchronization treatment (CRT) has moved into the mainstream of patient care after several randomized studies have demonstrated improved quality of life, reversed remodeling, and decreased heart failure hospitalizations. More recently, 2 large studies have demonstrated a mortality benefit of CRT independent of implantable cardioverter defibrillator
This review presents a substudy analysis of the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial, which examined the role of prophylactic implantable cardioverter defibrillator (ICD) implantation in patients with nonischemic cardiomyopathy.
Latest Monkeypox Trends, Vaccines and Public Health Policy by CDC, WHO
Environmental Factors Play a Role in Psychotic Experiences for Adolescent Twins
Early Time-Restricted Eating Effective for Weight Loss in Patients with Obesity